在沙特阿拉伯的喘患者中影响药物治疗和补充坚持因素:一个分层的随机横截面研究
Njoud M Alenezi1, Jawad S Alnajjar2, Areej H Alnajem3
1Hail Health Cluster, Hail, Saudi Arabia.
BMC pulmonary medicine
|December 20, 2025
概括
在沙特阿拉伯的阿尔阿萨,喘患者的不服药率很高,超过60%. 关键因素包括在感觉好转或由于副作用而停止服用药物,强调需要更好的支持和教育.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 公共卫生 公共卫生
- 临床药房 临床药房
背景情况:
- 喘是一种慢性炎症性呼吸道疾病,需要持续服药才能有效治疗.
- 对沙特阿拉伯的喘患者来说,药物坚持是一个重大挑战.
- 了解坚持模式对于改善患者的治疗结果至关重要.
研究的目的:
- 为了评估在沙特阿拉伯的阿尔阿赫萨的喘药物坚持水平.
- 确定与不遵守相关的人口,社会经济和医疗保健相关因素.
- 为改善药物守提供有针对性的干预信息.
主要方法:
- 一项涉及沙特阿拉伯Al-Ahsa成人喘患者的横截面研究 (2024年5月至7月).
- 分层的随机抽样和结构化的电话采访,使用验证的问卷.
- 描述性统计学,奇平方测试和多变量后勤回归分析.
主要成果:
- 在喘患者中观察到高不坚持率 (60.7%).
- 不服药的主要原因包括在症状改善后停止服用药物 (36.9%) 和出现副作用 (20.4%).
- 与更高的坚持相关的因素包括女性性别,更高的收入,婚姻,城市居住和药物支持;年龄较小,男性性别,收入较低和缺乏支持与不坚持有关.
结论:
- 在沙特阿拉伯的阿尔阿赫萨,不遵守喘药物很普遍.
- 人口,社会经济和医疗保健因素显著影响了遵守.
- 建议以支持系统,患者教育和获取为重点的干预措施来改善喘管理.
相关概念视频
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
Inhaled Medications
687
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
687
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K


